TAK-228 and TAK-117 Followed by Cisplatin and Nab Paclitaxel for Metastatic Triple Negative Breast Cancer
Clinical trial NCT03193853 · COMPLETED
Trial details
- NCT number
- NCT03193853
- Sponsor
- Joyce O'Shaughnessy
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-18
- Primary completion
- 2020-03-17
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.